About us

Founded in 2015 By Doctor Michael Shleifer with the vision of building a global diagnostics company that specializes in algorithm-based, machine learning, non-invasive diagnostics, delivering high-end medical services for patients and healthcare professionals in hepatology, gastroenterology and metabolic diseases.

Leadership Team

Applying the science of diagnostic algorithms & artificial intelligence to improve human health globally. We believe we can Improve early detection and diagnosis through non invasive algorithmic technology that advances clinical outcome.

LEADERSHIP TEAM

Fibronostics was founded in 2015 and comprises a team of physicians, data scientists and life science experts
driven to improve healthcare with technology.

Roni H Amiel

CEO

Thomas Fratacci

Chief Financial Officer

Dr Ronald Quiambao

Chief Medical Officer

Aida Jailani

Operations Director

Goh Gaik Lyn

Commercial Director

Abhishek Aravind

Chief Technology Officer

Our Team

Len Mancini

Sales Director (US)

Nelly Conus

Clinical Lead EU

Teresa Gonzalo

Medical and Science Director

LLoyd Isberto

Operations Manager (Philippines)

Chalakorn Cherdsaengkaew

Business Development Manager

Nurafiqah Maidin

Business Development Manager

BOARD OF DIRECTORS

Michael Shleifer

Co- founder and Managing Partner
SPRIM

Laurent Benissan

Managing Partner
SPRIM Ventures

Ivan Jarry

Co-founder and Managing Partner,
SPRIM

ADVISORY BOARD

Cathy Eddy

Founder and Retired President
Health Plan Alliance

Dr Imtiaz Alam MD

Clinical Associate Professor of Medicine
Texas A&M University

Sven Henrichwark

Medical Technology
SPRIM VENTURES
HealthFACTR Fibronostics
*
*
*
*